Page last updated: 2024-10-25

deferoxamine and Nasopharyngeal Neoplasms

deferoxamine has been researched along with Nasopharyngeal Neoplasms in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Nasopharyngeal Neoplasms: Tumors or cancer of the NASOPHARYNX.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yeung, HY1
Lai, KP1
Chan, HY1
Mak, NK1
Wagner, GF1
Wong, CK1
Mathias, CJ1
Wang, S1
Lee, RJ1
Waters, DJ1
Low, PS1
Green, MA1

Other Studies

2 other studies available for deferoxamine and Nasopharyngeal Neoplasms

ArticleYear
Hypoxia-inducible factor-1-mediated activation of stanniocalcin-1 in human cancer cells.
    Endocrinology, 2005, Volume: 146, Issue:11

    Topics: Cell Line, Tumor; Colonic Neoplasms; Deferoxamine; Female; Ferric Compounds; Ferricyanides; Glycopro

2005
Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:6

    Topics: Animals; Carrier Proteins; Deferoxamine; Endocytosis; Folate Receptors, GPI-Anchored; Folic Acid; Ma

1996